RP
Royalty Pharma
RPRX · NASDAQ
$63.96 +0.84% (+$0.53)
1M +12.67%
Market Cap $28.3B
P/E Ratio 34.73x
Div. Yield 1.42%
ROE 12.25%
Bulios Fair Price
$49.39
22.8% downside
Trenutna cena
$63.96
Podcenjeno Poštena vrednost Precenjeno
Po podatkih Bulios Fair Price je delnica RPRX trenutno precenjena glede na svojo tržno ceno. Kako deluje?
Bulios Fair Price je ocena poštene vrednosti delnice iz Buliosovega modela vrednotenja. Je vhod za vašo lastno analizo, ne naložbeno priporočilo. Kako deluje?
Piotroski F-Score Moderate
6/9Valuation
43 /100
Fair P/E 34.73x
EV/EBITDA 21.25x
P/S 11.17x
Growth
57 /100
Stable EPS growth 162.07%
Rev. growth 2.06%
FCF growth 5.11%
Profitability
100 /100
Strong Gross margin 89.38%
Net margin 32.15%
Op. margin 62.34%
Quality
43 /100
Average ROIC 8.08%
ROE 12.25%
ROA 4.11%
Debt
36 /100
Moderate Debt/Equity 1.31x
Current ratio 1.29x
Int. coverage 4.74x
Stability
59 /100
Moderate Beta 0.43x
Rev. volatility 5.21%
EPS volatility 1,411.73%
Bulios Scoring opisuje kakovost in preteklost podjetja, ne prihodnjega donosa. Visok rezultat ni nakupni signal. Izvedite več
Vprašajte StockBota o RPRX
Online
Sector
Healthcare
Industry
Medical - Pharmaceuticals
CEO
Pablo Legorreta
Employees
100
Headquarters
New York
Prihajajoči dogodki
04 NOV.
Earnings
Upcoming earnings report